Institutional-Level Differences in Quality and Outcomes of Lung Cancer Resections in the United States.

作者: Raymond U. Osarogiagbon , Helmneh M. Sineshaw , Chun Chieh Lin , Ahmedin Jemal

DOI: 10.1016/J.CHEST.2020.10.075

关键词:

摘要: Background Institutional-level disparities in non-small cell lung cancer (NSCLC) survival may be driven by reversible differences care-delivery processes. We quantified the impact of readily identifiable quality metrics on long-term resected NSCLC. Research Question How do oncologic care contribute to institutional-level early-stage NSCLC survival? Study Design and Methods retrospectively analyzed patients National Cancer Data Base who underwent resection from 2004 through 2015 within institutions categorized as Community, Comprehensive Integrated Network, Academic, Institute (NCI)-Designated Programs. estimated percentages adjusted ORs for six potentially avoidable poor-quality markers: incomplete resection, nonexamination lymph nodes, nonanatomic non-evidence-based use adjuvant chemotherapy, radiation therapy, 60-day postoperative mortality. By sequentially eliminating with markers calculating hazard ratios, we their overall impact. Results Of 169,775 patients, 7%, 46%, 10%, 24%, 12% underwent surgery at NCI-Designated Programs, 5-year rates 52%, 56%, 58%, 60% and 66%, respectively. After sequential elimination process, using Centers a reference, ratio changed 1.47 (95% CI, 1.41-1.53), 1.29 1.25-1.33), 1.18 1.14-1.23), 1.20 1.16-1.24) Networks, Academic Programs 1.35 1.28-1.42), 1.22 1.17-1.26), 1.16 1.11-1.22), 1.17 1.12-1.21), respectively (P  Interpretation Targeting identified narrowed, but did not eliminate, institutional disparities. The greatest was community programs. Residual factors driving persistent institution-level must characterized eliminate them.

参考文章(60)
, Reduced lung-cancer mortality with low-dose computed tomographic screening. The New England Journal of Medicine. ,vol. 365, pp. 395- 409 ,(2011) , 10.1056/NEJMOA1102873
Robert Pirker, Adjuvant chemotherapy in patients with completely resected non-small cell lung cancer Translational lung cancer research. ,vol. 3, pp. 305- 310 ,(2014) , 10.3978/J.ISSN.2218-6751.2014.09.13
Onkar V. Khullar, Yuan Liu, Theresa Gillespie, Kristin A. Higgins, Suresh Ramalingam, Joseph Lipscomb, Felix G Fernandez, Survival After Sublobar Resection versus Lobectomy for Clinical Stage IA Lung Cancer: An Analysis from the National Cancer Data Base. Journal of Thoracic Oncology. ,vol. 10, pp. 1625- 1633 ,(2015) , 10.1097/JTO.0000000000000664
John D. Birkmeyer, Justin B. Dimick, Nancy J.O. Birkmeyer, Measuring the quality of surgical care: structure, process, or outcomes? Journal of The American College of Surgeons. ,vol. 198, pp. 626- 632 ,(2004) , 10.1016/J.JAMCOLLSURG.2003.11.017
A. Donabedian, The quality of care. How can it be assessed? JAMA: The Journal of the American Medical Association. ,vol. 260, pp. 1743- 1748 ,(1988) , 10.1001/JAMA.260.12.1743
Chris R. Kelsey, Lawrence B. Marks, Donna Hollis, Jessica L. Hubbs, Neal E. Ready, Thomas A. D'Amico, Jessamy A. Boyd, Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients. Cancer. ,vol. 115, pp. 5218- 5227 ,(2009) , 10.1002/CNCR.24625
Christopher M. Pezzi, Katherine Mallin, Andres Samayoa Mendez, Emmelle Greer Gay, Joe B. Putnam, Ninety-day mortality after resection for lung cancer is nearly double 30-day mortality The Journal of Thoracic and Cardiovascular Surgery. ,vol. 148, pp. 2269- 2278 ,(2014) , 10.1016/J.JTCVS.2014.07.077
Raymond U. Osarogiagbon, Xinhua Yu, Nonexamination of Lymph Nodes and Survival After Resection of Non-Small Cell Lung Cancer The Annals of Thoracic Surgery. ,vol. 96, pp. 1178- 1189 ,(2013) , 10.1016/J.ATHORACSUR.2013.05.021
Edward B Garon, Naiyer A Rizvi, Rina Hui, Natasha Leighl, Ani S Balmanoukian, Joseph Paul Eder, Amita Patnaik, Charu Aggarwal, Matthew Gubens, Leora Horn, Enric Carcereny, Myung-Ju Ahn, Enriqueta Felip, Jong-Seok Lee, Matthew D Hellmann, Omid Hamid, Jonathan W Goldman, Jean-Charles Soria, Marisa Dolled-Filhart, Ruth Z Rutledge, Jin Zhang, Jared K Lunceford, Reshma Rangwala, Gregory M Lubiniecki, Charlotte Roach, Kenneth Emancipator, Leena Gandhi, None, Pembrolizumab for the treatment of non-small cell lung cancer The New England Journal of Medicine. ,vol. 372, pp. 2018- 2028 ,(2015) , 10.1056/NEJMOA1501824
Catherine C. Lerro, Anthony S. Robbins, Jerri Linn Phillips, Andrew K. Stewart, Comparison of Cases Captured in the National Cancer Data Base with Those in Population-based Central Cancer Registries Annals of Surgical Oncology. ,vol. 20, pp. 1759- 1765 ,(2013) , 10.1245/S10434-013-2901-1